PBSV (Pharma-Bio Serv) Cash-to-Debt : 80.75 (As of Jan. 2025)

Pharma-Bio Serv Cash-to-Debt Chart

Pharma-Bio Serv Annual Data
	Trend	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23	Oct24
Cash-to-Debt		Get a 7-Day Free Trial					6.29	28.31	29.64	43.29	65.70

Pharma-Bio Serv Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Cash-to-Debt	Get a 7-Day Free Trial															51.26	49.52	55.20	65.70	80.75

Competitive Comparison of Pharma-Bio Serv's Cash-to-Debt

For the Health Information Services subindustry, Pharma-Bio Serv's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma-Bio Serv's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Pharma-Bio Serv's Cash-to-Debt falls into.

Pharma-Bio Serv Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Pharma-Bio Serv's Cash to Debt Ratio for the fiscal year that ended in Oct. 2024 is calculated as:

Pharma-Bio Serv's Cash to Debt Ratio for the quarter that ended in Jan. 2025 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma-Bio Serv  (OTCPK:PBSV) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Pharma-Bio Serv Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Pharma-Bio Serv's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma-Bio Serv Business Description